Dasotraline Completed Phase 2 Trials for Major Depressive Disorder (MDD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00584974A Safety, Efficacy and Tolerability Study of SEP-225289